383 related articles for article (PubMed ID: 26583079)
1. Comprehensive identification of virulence factors required for respiratory melioidosis using Tn-seq mutagenesis.
Gutierrez MG; Yoder-Himes DR; Warawa JM
Front Cell Infect Microbiol; 2015; 5():78. PubMed ID: 26583079
[TBL] [Abstract][Full Text] [Related]
2. Type 3 secretion system cluster 3 is a critical virulence determinant for lung-specific melioidosis.
Gutierrez MG; Pfeffer TL; Warawa JM
PLoS Negl Trop Dis; 2015 Jan; 9(1):e3441. PubMed ID: 25569630
[TBL] [Abstract][Full Text] [Related]
3. Burkholderia pseudomallei Capsule Exacerbates Respiratory Melioidosis but Does Not Afford Protection against Antimicrobial Signaling or Bacterial Killing in Human Olfactory Ensheathing Cells.
Dando SJ; Ipe DS; Batzloff M; Sullivan MJ; Crossman DK; Crowley M; Strong E; Kyan S; Leclercq SY; Ekberg JAK; St John J; Beacham IR; Ulett GC
Infect Immun; 2016 Jul; 84(7):1941-1956. PubMed ID: 27091931
[TBL] [Abstract][Full Text] [Related]
4. Role for the Burkholderia pseudomallei capsular polysaccharide encoded by the wcb operon in acute disseminated melioidosis.
Warawa JM; Long D; Rosenke R; Gardner D; Gherardini FC
Infect Immun; 2009 Dec; 77(12):5252-61. PubMed ID: 19752033
[TBL] [Abstract][Full Text] [Related]
5. Functional characterizations of effector protein BipC, a type III secretion system protein, in Burkholderia pseudomallei pathogenesis.
Kang WT; Vellasamy KM; Chua EG; Vadivelu J
J Infect Dis; 2015 Mar; 211(5):827-34. PubMed ID: 25165162
[TBL] [Abstract][Full Text] [Related]
6. Development of novel animal infection models for the study of acute and chronic Burkholderia pseudomallei pulmonary infections.
van Schaik E; Tom M; DeVinney R; Woods DE
Microbes Infect; 2008 Oct; 10(12-13):1291-9. PubMed ID: 18707015
[TBL] [Abstract][Full Text] [Related]
7. Type III secretion system cluster 3 is required for maximal virulence of Burkholderia pseudomallei in a hamster infection model.
Warawa J; Woods DE
FEMS Microbiol Lett; 2005 Jan; 242(1):101-8. PubMed ID: 15621426
[TBL] [Abstract][Full Text] [Related]
8. Identification of a regulatory cascade controlling Type III Secretion System 3 gene expression in Burkholderia pseudomallei.
Sun GW; Chen Y; Liu Y; Tan GY; Ong C; Tan P; Gan YH
Mol Microbiol; 2010 May; 76(3):677-89. PubMed ID: 20345664
[TBL] [Abstract][Full Text] [Related]
9. Burkholderia pseudomallei as an Enteric Pathogen: Identification of Virulence Factors Mediating Gastrointestinal Infection.
Sanchez-Villamil JI; Tapia D; Borlee GI; Borlee BR; Walker DH; Torres AG
Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33106293
[No Abstract] [Full Text] [Related]
10.
Stockton JL; Khakhum N; Stevenson HL; Torres AG
mSphere; 2023 Oct; 8(5):e0037823. PubMed ID: 37768049
[No Abstract] [Full Text] [Related]
11. Virulence from the rhizosphere: ecology and evolution of Burkholderia pseudomallei-complex species.
French CT; Bulterys PL; Woodward CL; Tatters AO; Ng KR; Miller JF
Curr Opin Microbiol; 2020 Apr; 54():18-32. PubMed ID: 32028234
[No Abstract] [Full Text] [Related]
12. Melioidosis: molecular aspects of pathogenesis.
Stone JK; DeShazer D; Brett PJ; Burtnick MN
Expert Rev Anti Infect Ther; 2014 Dec; 12(12):1487-99. PubMed ID: 25312349
[TBL] [Abstract][Full Text] [Related]
13. Biodefense-driven murine model of pneumonic melioidosis.
Jeddeloh JA; Fritz DL; Waag DM; Hartings JM; Andrews GP
Infect Immun; 2003 Jan; 71(1):584-7. PubMed ID: 12496217
[TBL] [Abstract][Full Text] [Related]
14. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis.
Galyov EE; Brett PJ; DeShazer D
Annu Rev Microbiol; 2010; 64():495-517. PubMed ID: 20528691
[TBL] [Abstract][Full Text] [Related]
15. A proteasome inhibitor produced by Burkholderia pseudomallei modulates intracellular growth.
Wagley S; Vanaporn M; Rinchai D; Conejero L; Lertmemongkolchai G; Bancroft GJ; Titball RW
Microb Pathog; 2017 Jun; 107():175-180. PubMed ID: 28323151
[TBL] [Abstract][Full Text] [Related]
16. Burkholderia pseudomallei known siderophores and hemin uptake are dispensable for lethal murine melioidosis.
Kvitko BH; Goodyear A; Propst KL; Dow SW; Schweizer HP
PLoS Negl Trop Dis; 2012; 6(6):e1715. PubMed ID: 22745846
[TBL] [Abstract][Full Text] [Related]
17. Experimental acute respiratory Burkholderia pseudomallei infection in BALB/c mice.
Lever MS; Nelson M; Stagg AJ; Beedham RJ; Simpson AJ
Int J Exp Pathol; 2009 Feb; 90(1):16-25. PubMed ID: 19200247
[TBL] [Abstract][Full Text] [Related]
18. Type III Secretion in the Melioidosis Pathogen
Vander Broek CW; Stevens JM
Front Cell Infect Microbiol; 2017; 7():255. PubMed ID: 28664152
[No Abstract] [Full Text] [Related]
19. Dual RNA-seq reveals a type 6 secretion system-dependent blockage of TNF-α signaling and BicA as a
Sanchez-Villamil JI; Tapia D; Khakhum N; Widen SG; Torres AG
Gut Microbes; 2022; 14(1):2111950. PubMed ID: 35984745
[TBL] [Abstract][Full Text] [Related]
20. Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant.
Reckseidler SL; DeShazer D; Sokol PA; Woods DE
Infect Immun; 2001 Jan; 69(1):34-44. PubMed ID: 11119486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
